|
|
Post by JHam on Sept 25, 2014 2:39:33 GMT
Looks like it is set to happen on Sept. 30th: www.smallcapnetwork.com/BrainStorm-Receives-Approval-for-Uplisting-to-the-NASDAQ-Capital-Market/s/via/18950/article/view/p/mid/1/id/5324/BrainStorm Receives Approval for Uplisting to the NASDAQ Capital Market NEW YORK, NEW YORK AND PETACH TIKVAH, ISRAEL , United States, via ETELIGIS INC., 09/24/2014 - - BrainStorm Cell Therapeutics Inc. ( OTCQB: BCLI, BCLID ), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that its shares of common stock have been approved for uplisting to the NASDAQ Capital Market, and hopes to commence trading on the NASDAQ Capital Market when trading begins on September 30, 2014. |
|
|
|
Post by JHam on Sept 25, 2014 3:28:20 GMT
I definitely think there will be some volatility in the next week prior to the up-list and especially the first few days after the up-list. I have a medium core position now, with some cash on the side ready to pounce if it gets crushed as soon as it is on the Nasdaq and shorted like crazy.
I think there will also be some long term sit-and-hold buyers though as well. Tony Fiorino said at Rodman & Renshaw (on a slide too) that one of the biggest goals of 2014 and going forward is aggressively introducing BCLI to the capital markets. I don't think they would go ahead with the r/s and up-list if at least a few institutions weren't lined up. Could be wishful thinking, but we'll see.
|
|
|
|
Post by JHam on Sept 25, 2014 12:59:46 GMT
Some mentioned somewhere about Fiorino buying 2,000 shares over the last few days. Lebovits just got into the act and bought 11,000 shares. Not a ton, but better then a sell and a nice gesture.
|
|
|
|
Post by selluwud on Sept 25, 2014 13:14:53 GMT
Looks like it is set to happen on Sept. 30th: www.smallcapnetwork.com/BrainStorm-Receives-Approval-for-Uplisting-to-the-NASDAQ-Capital-Market/s/via/18950/article/view/p/mid/1/id/5324/BrainStorm Receives Approval for Uplisting to the NASDAQ Capital Market NEW YORK, NEW YORK AND PETACH TIKVAH, ISRAEL , United States, via ETELIGIS INC., 09/24/2014 - - BrainStorm Cell Therapeutics Inc. ( OTCQB: BCLI, BCLID ), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that its shares of common stock have been approved for uplisting to the NASDAQ Capital Market, and hopes to commence trading on the NASDAQ Capital Market when trading begins on September 30, 2014. I see they registered for the NASDAQ on July 10, 2014. It would seem a good bet that ACT as well has registered. |
|
|
|
Post by stemman on Sept 29, 2014 19:39:05 GMT
Our last day in the Little League.
|
|
|
|
Post by lcd on Sept 29, 2014 21:51:35 GMT
Will be interesting to watch tomorrow. I feel like this stock is so far under the radar that right now it won't draw the scrutiny and day traders that ACTC\Ocata will when they uplist. I do hope BCLI put on some sort of roadshow to market their company to financial firms like companies do with an IPO.
|
|
|
|
Post by JHam on Sept 29, 2014 22:39:58 GMT
Will be interesting to watch tomorrow. I feel like this stock is so far under the radar that right now it won't draw the scrutiny and day traders that ACTC\Ocata will when they uplist. I do hope BCLI put on some sort of roadshow to market their company to financial firms like companies do with an IPO. Yep, tomorrow is the big day: mobile.reuters.com/article/idUSL6N0RT0L420140929?irpc=932BrainStorm shares to be listed on Nasdaq Capital Market TEL AVIV, SEPT 29 | Mon Sep 29, 2014 8:19am EDT TEL AVIV, Sept 29 (Reuters) - BrainStorm Cell Therapeutics Inc., an Israeli developer of adult stem cell treatments for neurodegenerative diseases, said its stock has been approved for listing on the Nasdaq Capital Market. Trading will begin on Sept. 30, the company said. BrainStorm is conducting clinical trials of its adult stem cell treatment in patients with amyotrophic lateral sclerosis (ALS). (Reporting by Tova Cohen) |
|
|
|
Post by JHam on Sept 29, 2014 22:45:21 GMT
lcd,
You could be right. I am totally expecting to see some volatility for a bit, but I also think Fiorino is aware of this and has some investors lined up, as well as some good news to go along with this up-list to try and keep things under control. I do agree that ACTC/OCATA will have it tougher.
|
|
|
|
Post by lcd on Sept 30, 2014 14:25:36 GMT
Well one hour into trading I was wrong, this is not interesting to watch. 6000 shares traded and the pps is up by only a few cents. It did briefly spike up to $4.35 and hopefully will continue to find support at higher levels but this stock needs more buyers.
|
|
